These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2052328)

  • 1. Controlled intraoral delivery of hydrocortisone sodium succinate.
    Brook IM; van Noort R; Pandurangi AV; Price A
    Oral Surg Oral Med Oral Pathol; 1991 Apr; 71(4):435-9. PubMed ID: 2052328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release from acrylic polymers via channels and cracks: in vitro studies with hydrocortisone.
    Brook IM; van Noort R
    Biomaterials; 1985 Jul; 6(4):281-5. PubMed ID: 4052543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of controlled and sustained release agents in dentistry: a review of applications for the control of dental caries.
    Mirth DB
    Pharmacol Ther Dent; 1980; 5(3-4):59-67. PubMed ID: 6938993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactoid reaction to intravenous hydrocortisone sodium succinate: a case report and literature review.
    Fulcher DA; Katelaris CH
    Med J Aust; 1991 Feb; 154(3):210-4. PubMed ID: 1888347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol controlled release by mesoporous silica.
    Lopez T; Ortiz E; Alexander-Katz R; Basaldella E; Bokhimi X
    Nanomedicine; 2009 Jun; 5(2):170-7. PubMed ID: 19091634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chitosan/gelatin/keratin composite containing hydrocortisone sodium succinate as a buccal mucoadhesive patch to treat desquamative gingivitis.
    Davoudi Z; Rabiee M; Houshmand B; Eslahi N; Khoshroo K; Rasoulianboroujeni M; Tahriri M; Tayebi L
    Drug Dev Ind Pharm; 2018 Jan; 44(1):40-55. PubMed ID: 28832260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling drug release from acrylic polymers: in vitro studies with potential oral inserts.
    Brook IM; Douglas CW; van Noort R
    Biomaterials; 1986 Jul; 7(4):292-6. PubMed ID: 3741966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of hydrocortisone acetate from dermal bases.
    Orienti I; Zecchi V; Ceschel G; Fini A
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():466-72. PubMed ID: 1820924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective delivery systems for prolonged fluoride release: review of literature.
    Hanes CM; Hanes PJ
    J Am Dent Assoc; 1986 Sep; 113(3):431-6. PubMed ID: 3531283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro iontophoretic studies using a synthetic membrane.
    Tu YH; Allen LV
    J Pharm Sci; 1989 Mar; 78(3):211-3. PubMed ID: 2724080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-coated tablets: a system for the controlled release of drugs.
    Källstrand G; Ekman B
    J Pharm Sci; 1983 Jul; 72(7):772-5. PubMed ID: 6886984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration.
    Semark AJ; Venkatesh K; McWhinney BC; Pretorius C; Roberts JA; Cohen J; Venkatesh B
    Crit Care Resusc; 2013 Mar; 15(1):63-6. PubMed ID: 23432505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorocoulometric determination of hydrocortisone and hydrocortisone acetate.
    Nikolić K; Medenica M; Bogavac M; Arsenijević L
    Farmaco; 1991 Apr; 46(4):623-6. PubMed ID: 1930555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
    Cheung YW; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1984 Sep; 41(9):1802-6. PubMed ID: 6496516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
    Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
    Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.